Idiopathic Pulmonary Fibrosis (Ipf) Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, China, Japan, Germany, UK - Size and Forecast 2024-2028

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Route of Administration
  • Executive Summary - Chart on Market Segmentation by Drug Class
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market

• 2.2 Market characteristics
  • Market characteristics analysis

• 2.3 Value chain analysis
  • Value Chain Analysis

3 Market Sizing

• 3.1 Market definition
  • Offerings of companies included in the market definition

• 3.2 Market segment analysis
  • Market segments

• 3.3 Market size 2023

• 3.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global Idiopathic Pulmonary Fibrosis (IPF) Market 2018 - 2022
  • Historic Market Size - Data Table on Global Idiopathic Pulmonary Fibrosis (IPF) Market 2018 - 2022 ($ million)

• 4.2 Route of Administration segment analysis 2018 - 2022
  • Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)

• 4.3 Drug Class segment analysis 2018 - 2022
  • Historic Market Size - Drug Class Segment 2018 - 2022 ($ million)

• 4.4 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ million)

• 4.5 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028

• 5.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028

• 5.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028

• 5.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028

• 5.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028

• 5.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028

• 5.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Route of Administration

• 6.1 Market segments
  • Chart on Route of Administration - Market share 2023-2028 (%)
  • Data Table on Route of Administration - Market share 2023-2028 (%)

• 6.2 Comparison by Route of Administration
  • Chart on Comparison by Route of Administration
  • Data Table on Comparison by Route of Administration

• 6.3 Oral - Market size and forecast 2023-2028
  • Chart on Oral - Market size and forecast 2023-2028 ($ million)
  • Data Table on Oral - Market size and forecast 2023-2028 ($ million)
  • Chart on Oral - Year-over-year growth 2023-2028 (%)
  • Data Table on Oral - Year-over-year growth 2023-2028 (%)

• 6.4 Parenteral - Market size and forecast 2023-2028
  • Chart on Parenteral - Market size and forecast 2023-2028 ($ million)
  • Data Table on Parenteral - Market size and forecast 2023-2028 ($ million)
  • Chart on Parenteral - Year-over-year growth 2023-2028 (%)
  • Data Table on Parenteral - Year-over-year growth 2023-2028 (%)

• 6.5 Market opportunity by Route of Administration
  • Market opportunity by Route of Administration ($ million)
  • Data Table on Market opportunity by Route of Administration ($ million)

7 Market Segmentation by Drug Class

• 7.1 Market segments
  • Chart on Drug Class - Market share 2023-2028 (%)
  • Data Table on Drug Class - Market share 2023-2028 (%)

• 7.2 Comparison by Drug Class
  • Chart on Comparison by Drug Class
  • Data Table on Comparison by Drug Class

• 7.3 Systemic corticosteroids - Market size and forecast 2023-2028
  • Chart on Systemic corticosteroids - Market size and forecast 2023-2028 ($ million)
  • Data Table on Systemic corticosteroids - Market size and forecast 2023-2028 ($ million)
  • Chart on Systemic corticosteroids - Year-over-year growth 2023-2028 (%)
  • Data Table on Systemic corticosteroids - Year-over-year growth 2023-2028 (%)

• 7.4 Immunosuppressants - Market size and forecast 2023-2028
  • Chart on Immunosuppressants - Market size and forecast 2023-2028 ($ million)
  • Data Table on Immunosuppressants - Market size and forecast 2023-2028 ($ million)
  • Chart on Immunosuppressants - Year-over-year growth 2023-2028 (%)
  • Data Table on Immunosuppressants - Year-over-year growth 2023-2028 (%)

• 7.5 Tyrosine kinase inhibitors - Market size and forecast 2023-2028
  • Chart on Tyrosine kinase inhibitors - Market size and forecast 2023-2028 ($ million)
  • Data Table on Tyrosine kinase inhibitors - Market size and forecast 2023-2028 ($ million)
  • Chart on Tyrosine kinase inhibitors - Year-over-year growth 2023-2028 (%)
  • Data Table on Tyrosine kinase inhibitors - Year-over-year growth 2023-2028 (%)

• 7.6 Anti-fibrotic agents - Market size and forecast 2023-2028
  • Chart on Anti-fibrotic agents - Market size and forecast 2023-2028 ($ million)
  • Data Table on Anti-fibrotic agents - Market size and forecast 2023-2028 ($ million)
  • Chart on Anti-fibrotic agents - Year-over-year growth 2023-2028 (%)
  • Data Table on Anti-fibrotic agents - Year-over-year growth 2023-2028 (%)

• 7.7 Market opportunity by Drug Class
  • Market opportunity by Drug Class ($ million)
  • Data Table on Market opportunity by Drug Class ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
  • Chart on Market share by geography 2023-2028 (%)
  • Data Table on Market share by geography 2023-2028 (%)

• 9.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison

• 9.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)

• 9.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)

• 9.5 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)

• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

• 9.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ million)
  • Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)

• 9.8 China - Market size and forecast 2023-2028
  • Chart on China - Market size and forecast 2023-2028 ($ million)
  • Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Chart on China - Year-over-year growth 2023-2028 (%)
  • Data Table on China - Year-over-year growth 2023-2028 (%)

• 9.9 Japan - Market size and forecast 2023-2028
  • Chart on Japan - Market size and forecast 2023-2028 ($ million)
  • Data Table on Japan - Market size and forecast 2023-2028 ($ million)
  • Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Data Table on Japan - Year-over-year growth 2023-2028 (%)

• 9.10 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)

• 9.11 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)

• 9.12 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

• 10.1 Market drivers

• 10.2 Market challenges

• 10.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028

• 10.4 Market opportunities/restraints

11 Competitive Landscape

• 11.1 Overview

• 11.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation

• 11.3 Landscape disruption
  • Overview on factors of disruption

• 11.4 Industry risks
  • Impact of key risks on business

12 Competitive Analysis

• 12.1 Companies profiled
  • Companies covered

• 12.2 Market positioning of companies
  • Matrix on companies position and classification

• 12.3 AstraZeneca Plc
  • AstraZeneca Plc - Overview
  • AstraZeneca Plc - Product / Service
  • AstraZeneca Plc - Key news
  • AstraZeneca Plc - Key offerings

• 12.4 Boehringer Ingelheim International GmbH
  • Boehringer Ingelheim International GmbH - Overview
  • Boehringer Ingelheim International GmbH - Product / Service
  • Boehringer Ingelheim International GmbH - Key news
  • Boehringer Ingelheim International GmbH - Key offerings

• 12.5 Bristol Myers Squibb Co.
  • Bristol Myers Squibb Co. - Overview
  • Bristol Myers Squibb Co. - Product / Service
  • Bristol Myers Squibb Co. - Key news
  • Bristol Myers Squibb Co. - Key offerings

• 12.6 Cipla Inc.
  • Cipla Inc. - Overview
  • Cipla Inc. - Business segments
  • Cipla Inc. - Key news
  • Cipla Inc. - Key offerings
  • Cipla Inc. - Segment focus

• 12.7 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus

• 12.8 FibroGen Inc.
  • FibroGen Inc. - Overview
  • FibroGen Inc. - Product / Service
  • FibroGen Inc. - Key offerings

• 12.9 Galapagos NV
  • Galapagos NV - Overview
  • Galapagos NV - Product / Service
  • Galapagos NV - Key offerings

• 12.10 GNI Group Ltd.
  • GNI Group Ltd. - Overview
  • GNI Group Ltd. - Product / Service
  • GNI Group Ltd. - Key offerings

• 12.11 Horizon Therapeutics Plc
  • Horizon Therapeutics Plc - Overview
  • Horizon Therapeutics Plc - Product / Service
  • Horizon Therapeutics Plc - Key offerings

• 12.12 Jubilant Pharmova Ltd.
  • Jubilant Pharmova Ltd. - Overview
  • Jubilant Pharmova Ltd. - Business segments
  • Jubilant Pharmova Ltd. - Key news
  • Jubilant Pharmova Ltd. - Key offerings
  • Jubilant Pharmova Ltd. - Segment focus

• 12.13 Liminal BioSciences Inc.
  • Liminal BioSciences Inc. - Overview
  • Liminal BioSciences Inc. - Product / Service
  • Liminal BioSciences Inc. - Key offerings

• 12.14 MediciNova Inc.
  • MediciNova Inc. - Overview
  • MediciNova Inc. - Product / Service
  • MediciNova Inc. - Key offerings

• 12.15 Novartis AG
  • Novartis AG - Overview
  • Novartis AG - Business segments
  • Novartis AG - Key news
  • Novartis AG - Key offerings
  • Novartis AG - Segment focus

• 12.16 SHIONOGI Co. Ltd.
  • SHIONOGI Co. Ltd. - Overview
  • SHIONOGI Co. Ltd. - Product / Service
  • SHIONOGI Co. Ltd. - Key offerings

• 12.17 United Therapeutics Corp.
  • United Therapeutics Corp. - Overview
  • United Therapeutics Corp. - Product / Service
  • United Therapeutics Corp. - Key offerings

13 Appendix

• 13.1 Scope of the report

• 13.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist

• 13.3 Currency conversion rates for US$
  • Currency conversion rates for US$

• 13.4 Research methodology
  • Research methodology

• 13.5 Data procurement
  • Information sources

• 13.6 Data validation
  • Data validation

• 13.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing

• 13.8 Data synthesis
  • Data synthesis

• 13.9 360 degree market analysis
  • 360 degree market analysis

• 13.10 List of abbreviations
  • List of abbreviations